I like this statement. It suggests no rash decisions will be made re partnering. "YM will entertain strategic discussions with other companies for the next stages of development for CYT387 and will weigh any opportunities against the prospect of retaining full commercial economics by advancing CYT387 further into pivotal trials on its own"
"will weigh any opportunities against the prospect of retaining full commercial economics"
It is just me or is this almost sounding like M&A? If rumors begin to float this is being shopped them the stock should make a steady march north. Maybe $4 is too much but $3.50 isn't and any butout should be at 2x that plus contigency rights so if 387 works we see the upside. M&A is on fire right now. It's well within the realm of possibilities. Remember YM's platform and other candidates.